Adaptive Biotechnologies Corp

ADPT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001478320

SEC filings (opens in a new tab)

In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 12 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.

Q3 2024 vs. Q2 2024

How the institutions holding Adaptive Biotechnologies Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of ADPT: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	177	2	187	+12
Shares	148.8M	11.7M	143.1M	+6.01M (+4.4%)
Value	$538.6M	$42.3M	$732.5M	+$236.3M (+47.6%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Adaptive Biotechnologies Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to ADPT in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	11,932,841	$61.1M	0.00%
Blue Water Life Science Advisors, LLC	2,145,145	$11.0M	9.66%
Clearline Capital LP	614,593	$3.15M	0.28%
Point72 Asset Management, L.P.	495,492	$2.54M	0.01%
Driehaus Capital Management LLC	435,294	$2.23M	0.02%
Cubist Systematic Strategies, LLC	299,281	$1.53M	0.02%
Millrace Asset Group, Inc.	272,681	$1.40M	1.42%
Acadian Asset Management LLC	177,689	$908.0K	0.00%
Jacobs Levy Equity Management, Inc	143,679	$735.6K	0.00%
AJOVista, LLC	56,270	$288.1K	1.23%
Two Sigma Investments, LP	52,360	$268.1K	0.00%
Gsa Capital Partners LLP	48,165	$247.0K	0.02%
HRT Financial LP	44,969	$230.0K	0.00%
Dynamic Technology Lab Private Ltd	34,583	$177.0K	0.02%
Intech Investment Management LLC	34,293	$175.6K	0.00%
Point72 (DIFC) Ltd	19,637	$100.5K	0.01%
Centiva Capital, LP	15,635	$80.1K	0.00%
Squarepoint Ops LLC	12,154	$62.2K	0.00%
Amundi	11,001	$57.8K	0.00%
TownSquare Capital, LLC	11,018	$56.4K	0.00%
Two Sigma Advisers, LP	10,400	$53.2K	0.00%
Ashton Thomas Securities, LLC	6,685	$34.2K	0.01%
JTC Employer Solutions Trusteee Ltd	5,109	$26.0K	0.00%
Group One Trading, L.P.	1,619	$8.29K	0.00%
Bryn Mawr Trust Co	1,450	$7.42K	0.00%
Capital Performance Advisors LLP	764	$3.91K	0.00%
Sterling Capital Management LLC	403	$2.06K	0.00%
True Wealth Design, LLC	195	$999	0.00%
Bokf, NA	116	$587	0.00%
Ronald Blue Trust, Inc.	91	$329	0.00%
Northwestern Mutual Wealth Management Co	24	$123	0.00%
Hemington Wealth Management	200	$0	0.00%

Sold out (20)

Institutions that held Adaptive Biotechnologies Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of ADPT in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Tejara Capital Ltd	909,061	$3.29M
Franklin Resources Inc	127,975	$463.3K
Deerfield Management Company, L.P. (Series C)	122,841	$444.7K
Y-Intercept (Hong Kong) Ltd	67,252	$243.5K
Vident Advisory, LLC	48,016	$173.8K
Toroso Investments, LLC	32,229	$116.7K
Balyasny Asset Management LLC	29,227	$105.8K
Moloney Securities Asset Management, LLC	25,000	$90.5K
Principal Financial Group Inc	17,495	$63.3K
Nebula Research & Development LLC	15,011	$54.3K
Mutual Advisors, LLC	10,040	$44.6K
Atom Investors LP	10,954	$39.7K
MQS Management LLC	10,033	$36.3K
Optiver Holding B.V.	1,805	$6.53K
Redwood Wealth Management Group, LLC	1,710	$6.19K
Arcadia Investment Management Corp	1,000	$3.62K
National Bank of Canada	703	$2.51K
GAMMA Investing LLC	216	$782
Mather Group, LLC.	30	$96
Comerica Bank	13	$47

Not filed for Q3 2024 yet (2)

Institutions that held Adaptive Biotechnologies Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADPT in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	11,664,002	$42.2M
Susquehanna Fundamental Investments, LLC	34,276	$124.1K